quinoxalines has been researched along with Glaucoma, Angle Closure in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bauters, G; Borderie, V; Bouheraoua, N; Paques, M | 1 |
| Danwiriyakul, W; Kitnarong, N; Metheetrairut, A; Ruangvaravate, N | 1 |
| Faulkner, W | 1 |
| Aung, T; Chan, YH; Chew, PT; Ho, CL; Khoo, BK; Liu, YP; Oen, FT; Seah, SK; See, J; Thean, LH; Viswanathan, AC; Wong, HT | 1 |
| Iveković, R; Korsić, J; Mandić, Z; Masnec-Paskvalin, S; Novak-Laus, K; Zorić-Geber, M | 1 |
| Cha, SC; Glover, BK; Kim, C; Kim, YY; Nguyen, KD; Shin, DH | 1 |
| Chen, YF; Hsiao, CK; Hsieh, JW; Hung, PT; Shein, J | 1 |
4 trial(s) available for quinoxalines and Glaucoma, Angle Closure
| Article | Year |
|---|---|
Efficacy of brimonidine 0.2 per cent as adjunctive therapy to beta-blockers: a comparative study between POAG and CACG in Asian eyes.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Brimonidine Tartrate; Drug Therapy, Combination; Female; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Prospective Studies; Quinoxalines; Thailand; Treatment Outcome | 2002 |
Randomised controlled trial comparing the effect of brimonidine and timolol on visual field loss after acute primary angle closure.
Topics: Acute Disease; Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Disease Progression; Female; Glaucoma, Angle-Closure; Humans; Linear Models; Male; Middle Aged; Prospective Studies; Quinoxalines; Timolol; Visual Field Tests; Visual Fields | 2004 |
[Use of antiglaucoma therapy to reduce acute intraocular pressure rise following neodymium: YAG laser iridotomy in angle-closure glaucoma patients].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Female; Glaucoma, Angle-Closure; Humans; Iris; Laser Therapy; Latanoprost; Male; Middle Aged; Miotics; Ocular Hypertension; Pilocarpine; Postoperative Complications; Prostaglandins F, Synthetic; Quinoxalines | 2006 |
Long-term brimonidine therapy in glaucoma patients with apraclonidine allergy.
Topics: Adrenergic alpha-Agonists; Aged; Brimonidine Tartrate; Chronic Disease; Clonidine; Drug Hypersensitivity; Female; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Quinoxalines | 1999 |
3 other study(ies) available for quinoxalines and Glaucoma, Angle Closure
| Article | Year |
|---|---|
Reversible corneal stromal thinning, acute-onset white cataract and angle-closure glaucoma due to erdafitinib, a fibroblast growth factor receptor inhibitor: Report of three cases.
Topics: Cataract; Glaucoma, Angle-Closure; Humans; Pyrazoles; Quinoxalines; Receptors, Fibroblast Growth Factor; Retrospective Studies | 2021 |
Miotic effect of alphagan P.
Topics: Adrenergic alpha-Agonists; Aged; Aged, 80 and over; Brimonidine Tartrate; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Iris Diseases; Pupil; Quinoxalines | 2003 |
The efficacy of brimonidine in preventing intraocular pressure elevation in the provocative test for primary angle-closure glaucoma.
Topics: Adult; Aged; Brimonidine Tartrate; Darkness; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Male; Middle Aged; Posture; Prone Position; Quinoxalines | 2002 |